SIMAP--the database of all-against-all protein sequence similarities and annotations with new interfaces and increased coverage

The Similarity Matrix of Proteins (SIMAP, http://mips.gsf.de/simap/) database has been designed to massively accelerate computationally expensive protein sequence analysis tasks in bioinformatics. It provides pre-calculated sequence similarities interconnecting the entire known protein sequence universe, complemented by pre-calculated protein features and domains, similarity clusters and functional annotations. SIMAP covers all major public protein databases as well as many consistently re-annotated metagenomes from different repositories. As of September 2013, SIMAP contains >163 million proteins corresponding to ∼70 million non-redundant sequences. SIMAP uses the sensitive FASTA search heuristics, the Smith–Waterman alignment algorithm, the InterPro database of protein domain models and the BLAST2GO functional annotation algorithm. SIMAP assists biologists by facilitating the interactive exploration of the protein sequence universe. Web-Service and DAS interfaces allow connecting SIMAP with any other bioinformatic tool and resource. All-against-all protein sequence similarity matrices of project-specific protein collections are generated on request. Recent improvements allow SIMAP to cover the rapidly growing sequenced protein sequence universe. New Web-Service interfaces enhance the connectivity of SIMAP. Novel tools for interactive extraction of protein similarity networks have been added. Open access to SIMAP is provided through the web portal; the portal also contains instructions and links for software access and flat file downloads

High-level production of animal-free recombinant transferrin from saccharomyces cerevisiae

<p>Abstract</p> <p>Background</p> <p>Animal-free recombinant proteins provide a safe and effective alternative to tissue or serum-derived products for both therapeutic and biomanufacturing applications. While recombinant insulin and albumin already exist to replace their human counterparts in cell culture media, until recently there has been no equivalent for serum transferrin.</p> <p>Results</p> <p>The first microbial system for the high-level secretion of a recombinant transferrin (rTf) has been developed from <it>Saccharomyces cerevisiae </it>strains originally engineered for the commercial production of recombinant human albumin (Novozymes' Recombumin^®USP-NF) and albumin fusion proteins (Novozymes' albufuse^®). A full-length non-N-linked glycosylated rTf was secreted at levels around ten-fold higher than from commonly used laboratory strains. Modification of the yeast 2 μm-based expression vector to allow overexpression of the ER chaperone, protein disulphide isomerase, further increased the secretion of rTf approximately twelve-fold in high cell density fermentation. The rTf produced was functionally equivalent to plasma-derived transferrin.</p> <p>Conclusions</p> <p>A <it>Saccharomyces cerevisiae </it>expression system has enabled the cGMP manufacture of an animal-free rTf for industrial cell culture application without the risk of prion and viral contamination, and provides a high-quality platform for the development of transferrin-based therapeutics.</p

Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers

BACKGROUND: Many breast, pancreatic, colonic and non-small-cell lung carcinoma lines express CEACAM6 (NCA-90) and CEACAM5 (carcinoembryonic antigen, CEA), and antibodies to both can affect tumor cell growth in vitro and in vivo. Here, we compare both antigens as a function of histological phenotype in breast, pancreatic, lung, ovarian, and prostatic cancers, including patient-matched normal, primary tumor, and metastatic breast and colonic cancer specimens. METHODS: Antigen expression was determined by immunohistochemistry (IHC) using tissue microarrays with MN-15 and MN-3 antibodies targeting the A1B1- and N-domains of CEACAM6, respectively, and the MN-14 antibody targeting the A3B3 domain of CEACAM5. IHC was performed using avidin-biotin-diaminobenzide staining. The average score ± SD (0 = negative/8 = highest) for each histotype was recorded. RESULTS: For all tumors, the amount of CEACAM6 expressed was greater than that of CEACAM5, and reflected tumor histotype. In breast tumors, CEACAM6 was highest in papillary > infiltrating ductal > lobular > phyllodes; in pancreatic tumors, moderately-differentiated > well-differentiated > poorly-differentiated tumors; mucinous ovarian adenocarcinomas had almost 3-fold more CEACAM6 than serous ovarian adenocarcinomas; lung adenocarcinomas > squamous tumors; and liver metastases of colonic carcinoma > primary tumors = lymph nodes metastases > normal intestine. However, CEACAM6 expression was similar in prostate cancer and normal tissues. The amount of CEACAM6 in metastatic colon tumors found in liver was higher than in many primary colon tumors. In contrast, CEACAM6 immunostaining of lymph node metastases from breast, colon, or lung tumors was similar to the primary tumor. CONCLUSION: CEACAM6 expression is elevated in many solid tumors, but variable as a function of histotype. Based on previous work demonstrating a role for CEACAM6 in tumor cell migration, invasion and adhesion, and formation of distant metastases (Blumenthal et al., Cancer Res 65: 8809–8817, 2005), it may be a promising target for antibody-based therapy

Uterine electromyography for discrimination of labor imminence in women with threatened preterm labor under tocolytic treatment

[EN] As one of the main aims of obstetrics is to be able to detect imminent delivery in patients with threatened preterm labor, the techniques currently used in clinical practice have serious limitations in this respect. The electrohysterogram (EHG) has now emerged as an alternative technique, providing relevant information about labor onset when recorded in controlled checkups without administration of tocolytic drugs. The studies published to date mainly focus on EHG-burst analysis and, to a lesser extent, on whole EHG window analysis. The study described here assessed the ability of EHG signals to discriminate imminent labor (The ability of EHG recordings to predict imminent labor (<7days) was analyzed in preterm threatened patients undergoing tocolytic therapies by means of EHG-burst and whole EHG window analysis. The non-linear features were found to have better performance than the temporal and spectral parameters in separating women who delivered in less than 7days from those who did not.Mas-Cabo, J.; Prats-Boluda, G.; Perales Marín, AJ.; Garcia-Casado, J.; Alberola Rubio, J.; Ye Lin, Y. (2019). Uterine electromyography for discrimination of labor imminence in women with threatened preterm labor under tocolytic treatment. Medical & Biological Engineering & Computing. 57:401-411. https://doi.org/10.1007/s11517-018-1888-yS40141157Aboy M, Cuesta-Frau D, Austin D, Micó-Tormos P (2007) Characterization of sample entropy in the context of biomedical signal analysis. Conf Proc IEEE Eng Med Biol Soc:5942–5945. https://doi.org/10.1109/IEMBS.2007.4353701Aboy M, Hornero R, Abásolo D, Álvarez D (2006) Interpretation of the Lempel-Ziv complexity measure in the context of biomedical signal analysis. IEEE Trans Biomed Eng 53:2282–2288. https://doi.org/10.1109/TBME.2006.883696Chkeir A, Fleury MJ, Karlsson B, Hassan M, Marque C (2013) Patterns of electrical activity synchronization in the pregnant rat uterus. Biomed 3:140–144. https://doi.org/10.1016/j.biomed.2013.04.007Crandon AJ (1979) Maternal anxiety and neonatal wellbeing. J Psychosom Res 23:113–115. https://doi.org/10.1016/0022-3999(79)90015-1Devedeux D, Marque C, Mansour S, Germain G, Duchêne J (1993) Uterine electromyography: a critical review. Am J Obstet Gynecol 169:1636–1653. https://doi.org/10.1016/0002-9378(93)90456-SFele-Žorž G, Kavšek G, Novak-Antolič Ž, Jager F (2008) A comparison of various linear and non-linear signal processing techniques to separate uterine EMG records of term and pre-term delivery groups. Med Biol Eng Comput 46:911–922. https://doi.org/10.1007/s11517-008-0350-yFergus P, Cheung P, Hussain A, al-Jumeily D, Dobbins C, Iram S (2013) Prediction of preterm deliveries from EHG signals using machine learning. PLoS One 8:e77154. https://doi.org/10.1371/journal.pone.0077154Garfield RE, Maner WL (2006) Biophysical methods of prediction and prevention of preterm labor: uterine electromyography and cervical light-induced fluorescence—new obstetrical diagnostic techniques. In: Preterm Birth pp 131–144Garfield RE, Maner WL (2007) Physiology and electrical activity of uterine contractions. Semin Cell Dev Biol 18:289–295. https://doi.org/10.1016/j.semcdb.2007.05.004Garfield RE, Maner WL, MacKay LB et al (2005) Comparing uterine electromyography activity of antepartum patients versus term labor patients. Am J Obstet Gynecol 193:23–29. https://doi.org/10.1016/j.ajog.2005.01.050Goldenberg RL, Culhane JF, Iams JD, Romero R (2008) Epidemiology and causes of preterm birth. Lancet 371:75–84. https://doi.org/10.1016/S0140-6736(08)60074-4American College of Obstetricians and Gynecologists and Committee on Practice Bulletins— Obstetrics (2012) Practice bulletin no. 127. Obstet Gynecol 119(6):1308–1317.Hadar E, Biron-Shental T, Gavish O, Raban O, Yogev Y (2015) A comparison between electrical uterine monitor, tocodynamometer and intra uterine pressure catheter for uterine activity in labor. J Matern Neonatal Med 28:1367–1374. https://doi.org/10.3109/14767058.2014.954539Hans P, Dewandre P, Brichant JF, Bonhomme V (2005) Comparative effects of ketamine on Bispectral Index and spectral entropy of the electroencephalogram under sevoflurane anaesthesia. Br J Anaesth 94:336–340. https://doi.org/10.1093/bja/aei047Hassan M, Terrien J, Marque C, Karlsson B (2011) Comparison between approximate entropy, correntropy and time reversibility: application to uterine electromyogram signals. Med Eng Phys 33:980–986. https://doi.org/10.1016/j.medengphy.2011.03.010Hassan M, Terrien J, Muszynski C et al (2013) Better pregnancy monitoring using nonlinear correlation analysis of external uterine electromyography. IEEE Trans Biomed Eng 60:1160–1166. https://doi.org/10.1109/TBME.2012.2229279Horoba K, Jezewski J, Matonia A, Wrobel J, Czabanski R, Jezewski M (2016) Early predicting a risk of preterm labour by analysis of antepartum electrohysterograhic signals. Biocybern Biomed Eng 36:574–583. https://doi.org/10.1016/j.bbe.2016.06.004Lawn JE, Wilczynska-Ketende K, Cousens SN (2006) Estimating the causes of 4 million neonatal deaths in the year 2000. Int J Epidemiol 35:706–718. https://doi.org/10.1093/ije/dyl043Lemancewicz A, Borowska M, Kuć P, Jasińska E, Laudański P, Laudański T, Oczeretko E (2016) Early diagnosis of threatened premature labor by electrohysterographic recordings—the use of digital signal processing. Biocybern Biomed Eng 36:302–307. https://doi.org/10.1016/j.bbe.2015.11.005M L WLM, LR C (2012) Noninvasive uterine electromyography for prediction of preterm delivery. Am J Obstet Gynecol 204:1–20. https://doi.org/10.1016/j.ajog.2010.09.024.NoninvasiveManer WL, Garfield RE (2007) Identification of human term and preterm labor using artificial neural networks on uterine electromyography data. Ann Biomed Eng 35:465–473. https://doi.org/10.1007/s10439-006-9248-8Maner WL, Garfield RE, Maul H, Olson G, Saade G (2003) Predicting term and preterm delivery with transabdominal uterine electromyography. Obstet Gynecol 101:1254–1260. https://doi.org/10.1016/S0029-7844(03)00341-7Marque C, Gondry J (1999) Use of the electrohysterogram signal for characterization of contractions during pregnancy. IEEE Trans Biomed Eng 46:1222–1229Maul H, Maner WL, Olson G, Saade GR, Garfield RE (2004) Non-invasive transabdominal uterine electromyography correlates with the strength of intrauterine pressure and is predictive of labor and delivery. J Matern Fetal Neonatal Med 15:297–301Mischi M, Chen C, Ignatenko T, de Lau H, Ding B, Oei SGG, Rabotti C (2018) Dedicated entropy measures for early assessment of pregnancy progression from single-channel electrohysterography. IEEE Trans Biomed Eng 65:875–884. https://doi.org/10.1109/TBME.2017.2723933Most O, Langer O, Kerner R, Ben David G, Calderon I (2008) Can myometrial electrical activity identify patients in preterm labor? Am J Obstet Gynecol 199:378. https://doi.org/10.1016/j.ajog.2008.08.003Petrou S (2005) The economic consequences of preterm birth during the first 10 years of life. BJOG 112:10–15. https://doi.org/10.1111/j.1471-0528.2005.00577.xRabotti C, Sammali F, Kuijsters N, et al (2015) Analysis of uterine activity in nonpregnant women by electrohysterography: a feasibility study. In: Proc Annu Int Conf IEEE Eng Med Biol Soc EMBS pp 5916–5919Schlembach D, Maner WL, Garfield RE, Maul H (2009) Monitoring the progress of pregnancy and labor using electromyography. Eur J Obstet Gynecol Reprod Biol 144:2–8. https://doi.org/10.1016/j.ejogrb.2009.02.016Sikora J, Matonia A, Czabański R et al (2011) Recognition of premature threatening labour symptoms from bioelectrical uterine activity signals. Arch Perinat Med 17:97–103Vinken MPGC, Rabotti C, Mischi M, van Laar JOEH, Oei SG (2010) Nifedipine-induced changes in the electrohysterogram of preterm contractions: feasibility in clinical practice. Obstet Gynecol Int 2010:325635. https://doi.org/10.1155/2010/325635Vrhovec J, Lebar AM (2012) An uterine electromyographic activity as a measure of labor progression. Appl EMG Clin Sport Med 243–268. doi: https://doi.org/10.5772/25526Vrhovec J, Macek-Lebar A, Rudel D (2007) Evaluating uterine electrohysterogram with entropy. 11th Mediterr Conf Med Biomed Eng Comput 144–147. https://doi.org/10.1007/978-3-540-73044-6_36Ye-Lin Y, Bueno-Barrachina JM, Prats-boluda G, Rodriguez de Sanabria R, Garcia-Casado J (2017) Wireless sensor node for non-invasive high precision electrocardiographic signal acquisition based on a multi-ring electrode. Measurement 97:195–202. https://doi.org/10.1016/J.MEASUREMENT.2016.11.009Ye-Lin Y, Garcia-Casado J, Prats-Boluda G, Alberola-Rubio J, Perales A (2014) Automatic identification of motion artifacts in EHG recording for robust analysis of uterine contractions. Comput Math Methods Med 2014:1–11. https://doi.org/10.1155/2014/470786Zhang XS, Roy RJ, Jensen EW (2001) EEG complexity as a measure of depth of anesthesia for patients. IEEE Trans Biomed Eng 48:1424–1433. https://doi.org/10.1109/10.96660

The psychological science accelerator’s COVID-19 rapid-response dataset

In response to the COVID-19 pandemic, the Psychological Science Accelerator coordinated three large-scale psychological studies to examine the effects of loss-gain framing, cognitive reappraisals, and autonomy framing manipulations on behavioral intentions and affective measures. The data collected (April to October 2020) included specific measures for each experimental study, a general questionnaire examining health prevention behaviors and COVID-19 experience, geographical and cultural context characterization, and demographic information for each participant. Each participant started the study with the same general questions and then was randomized to complete either one longer experiment or two shorter experiments. Data were provided by 73,223 participants with varying completion rates. Participants completed the survey from 111 geopolitical regions in 44 unique languages/dialects. The anonymized dataset described here is provided in both raw and processed formats to facilitate re-use and further analyses. The dataset offers secondary analytic opportunities to explore coping, framing, and self-determination across a diverse, global sample obtained at the onset of the COVID-19 pandemic, which can be merged with other time-sampled or geographic data

Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients with type 2 diabetes. METHODS In this double-blind, randomized trial, we assigned patients with type 2 diabetes and albuminuric chronic kidney disease to receive canagliflozin, an oral SGLT2 inhibitor, at a dose of 100 mg daily or placebo. All the patients had an estimated glomerular filtration rate (GFR) of 30 to &lt;90 ml per minute per 1.73 m2 of body-surface area and albuminuria (ratio of albumin [mg] to creatinine [g], &gt;300 to 5000) and were treated with renin–angiotensin system blockade. The primary outcome was a composite of end-stage kidney disease (dialysis, transplantation, or a sustained estimated GFR of &lt;15 ml per minute per 1.73 m2), a doubling of the serum creatinine level, or death from renal or cardiovascular causes. Prespecified secondary outcomes were tested hierarchically. RESULTS The trial was stopped early after a planned interim analysis on the recommendation of the data and safety monitoring committee. At that time, 4401 patients had undergone randomization, with a median follow-up of 2.62 years. The relative risk of the primary outcome was 30% lower in the canagliflozin group than in the placebo group, with event rates of 43.2 and 61.2 per 1000 patient-years, respectively (hazard ratio, 0.70; 95% confidence interval [CI], 0.59 to 0.82; P=0.00001). The relative risk of the renal-specific composite of end-stage kidney disease, a doubling of the creatinine level, or death from renal causes was lower by 34% (hazard ratio, 0.66; 95% CI, 0.53 to 0.81; P&lt;0.001), and the relative risk of end-stage kidney disease was lower by 32% (hazard ratio, 0.68; 95% CI, 0.54 to 0.86; P=0.002). The canagliflozin group also had a lower risk of cardiovascular death, myocardial infarction, or stroke (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P=0.01) and hospitalization for heart failure (hazard ratio, 0.61; 95% CI, 0.47 to 0.80; P&lt;0.001). There were no significant differences in rates of amputation or fracture. CONCLUSIONS In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a median follow-up of 2.62 years